Community-reported insights only, not medical advice. Data recency varies by source; check timestamps and confidence before making treatment decisions.

← Back to Brands

Greyscales

Community footprint analysis based on portfolio size and patient feedback.

Time Period:
Rank
56
Portfolio
2 Strains
Mentions (90d)
38
Brand Score (90d)
61
vs Market Avg: 64 vs All Time: 61
Below Average

Rating lower than the 90d community baseline.

Medication Portfolio (2)

Rank Strain Name Specs Mentions (90d) Score (90d) Historical Avg
98
25.0%
26
58
59
274
24.0%
12
67
67